(Q44352373)

English

The effects of RB101, a mixed inhibitor of enkephalin-catabolizing enzymes, on carrageenin-induced spinal c-Fos expression are completely blocked by beta-funaltrexamine, a selective mu-opioid receptor antagonist

scientific article published in July 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

The effects of RB101, a mixed inhibitor of enkephalin-catabolizing enzymes, on carrageenin-induced spinal c-Fos expression are completely blocked by beta-funaltrexamine, a selective mu-opioid receptor antagonist (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

0 references

author name string

Le Guen S

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Honoré P

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Catheline G

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Fournié-Zaluski MC

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Roques BP

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Besson JM

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 July 1999

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

834

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

200-206

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

c-fos Expression in rat lumbar spinal cord during the development of adjuvant-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Effects of opioids and non-opioids on c-Fos-like immunoreactivity induced in rat lumbar spinal cord neurons by noxious heat stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Opioid agonists and antagonists: an evaluation of their peripheral actions in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin Circuitry

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Prevention of degradation of endogenous enkephalins produces inhibition of nociceptive neurones in rat spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

"Mixed inhibitor-prodrug" as a new approach toward systemically active inhibitors of enkephalin-degrading enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

New bidentates as full inhibitors of enkephalin-degrading enzymes: synthesis and analgesic properties

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Inhibition of noxious stimulus-evoked pain behaviors and neuronal fos-like immunoreactivity in the spinal cord of the rat by supraspinal morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: Correlation of nociceptive behavior and c-fos expression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Aspirin and acetaminophen reduced both Fos expression in rat lumbar spinal cord and inflammatory signs produced by carrageenin inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Carrageenin-evoked c-Fos expression in rat lumbar spinal cord: the effects of indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

The effects of morphine on carrageenin-induced spinal c-Fos expression are completely blocked by beta-funaltrexamine, a selective mu-opioid receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Chronic treatment with systemic morphine induced tolerance to the systemic and peripheral antinociceptive effects of morphine on both carrageenin induced mechanical hyperalgesia and spinal c-Fos expression in awake rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Reduction of carrageenin oedema and the associated c-Fos expression in the rat lumbar spinal cord by nitric oxide synthase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

When is the maximal effect of pre-administered systemic morphine on carrageenin evoked spinal c-Fos expression in the rat?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Potent antinociceptive effects of kelatorphan (a highly efficient inhibitor of multiple enkephalin-degrading enzymes) systemically administered in normal and arthritic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Endogenous opioid peptides: multiple agonists and receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Antinociceptive response induced by mixed inhibitors of enkephalin catabolism in peripheral inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Regulation of gene expression by neurotransmitters in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Binding in vivo of selective mu and delta opioid receptor agonists: opioid receptor occupancy by endogenous enkephalins

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Kelatorphan potentiates the effect of [Met5]enkephalin in the substantia gelatinosa of the cat spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Assessment of endogenous enkephalins efficacy in the hot plate test in mice: comparative study with morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Peripheral opioid receptors mediating antinociception in inflammation. Activation by endogenous opioids and role of the pituitary-adrenal axis.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Antinociceptive effect of systemic PC 12, a prodrug mixed inhibitor of enkephalin-degrading enzymes, in normal and arthritic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Effect of beta-FNA on opiate delta receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

In vivo occupation of mouse brain opioid receptors by endogenous enkephalins: blockade of enkephalin degrading enzymes by RB 101 inhibits [3H]diprenorphine binding

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

On the specificity of naloxone as an opiate antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Analgesic responses elicited by endogenous enkephalins (protected by mixed peptidase inhibitors) in a variety of morphine-sensitive noxious tests.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Electrophysiological studies on the spinal roles of endogenous opioids in carrageenan inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Delta-opioid mediated inhibitions of acute and prolonged noxious-evoked responses in rat dorsal horn neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Effects of Kelatorphan and morphine before and after noxious stimulation on immediate-early gene expression in rat spinal cord neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Ethical guidelines for investigations of experimental pain in conscious animals

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901569-3

7 January 2021

Identifiers

10.1016/S0006-8993(99)01569-3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44352373&oldid=2109657796"